The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Twenty years of research on cytokine-induced sickness behavior
Dantzer, R., & Kelley, K. W. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.09.006 · Cited by 1,420
Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
Pace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., & Heim, C. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1630 · Cited by 810
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases
Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 779
Akhondzadeh, S., Jafari, S., Raisi, F., Nasehi, A. A., Ghoreishi, A., Salehi, B., Mohebbi-Rasa, S., Raznahan, M., & Kamalipour, A. (2009) · Depression and Anxiety · doi:10.1002/da.20589 · Cited by 397
Self-citationAlesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1667 · Cited by 372
Frommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362
Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine
SŁUŻEWSKA, A., RYBAKOWSKI, J. K., LACIAK, M., MACKIEWICZ, A., SOBIESKA, M., & WIKTOROWICV, K. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32372.x · Cited by 306
Hinson, R. M., Williams, J. A., & Shacter, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4885 · Cited by 302
Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298
AKHONDZADEH, S., TABATABAEE, M., AMINI, H., AHMADIABHARI, S., ABBASI, S., & BEHNAM, B. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.016 · Cited by 289
Self-citationGlaser, R., Robles, T. F., Sheridan, J., Malarkey, W. B., & Kiecolt-Glaser, J. K. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.10.1009 · Cited by 243
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240
IL-6 levels decrease with SSRI treatment in patients with major depression
Basterzi, A. D., Aydemir, Ç., Kisa, C., Aksaray, S., Tuzer, V., Yazici, K., & Göka, E. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.717 · Cited by 219
Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults.
Kiecolt-Glaser, J. K., Belury, M. A., Porter, K., Beversdorf, D. Q., Lemeshow, S., & Glaser, R. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3180313a45 · Cited by 212
Depression, immunocompetence, and prostaglandins of the E series
Calabrese, J. R., Skwerer, R. G., Barna, B., Gulledge, A. D., Valenzuela, R., Butkus, A., Subichin, S., & Krupp, N. E. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90040-5 · Cited by 205
Inflammatory markers in depression
Dinan, T. G. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328315a561 · Cited by 205
White, W. B., West, C. R., Borer, J. S., Gorelick, P. B., Lavange, L., Pan, S. X., Weiner, E., & Verburg, K. M. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.069 · Cited by 186
Casolini, P., Catalani, A., Zuena, A. R., & Angelucci, L. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10192 · Cited by 174
Song, C., Zhang, X. Y., & Manku, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3569-08.2009 · Cited by 169
Carlin, J. M., Borden, E. C., Sondel, P., & Byrne, G. I. (1987) · Journal of Immunology · doi:10.4049/jimmunol.139.7.2414 · Cited by 160
Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes.
Musso, T., Gusella, G., Brooks, A., Longo, D., & Varesio, L. (1994) · Blood · doi:10.1182/blood.v83.5.1408.1408 · Cited by 158
CSF Prostaglandin Levels in Depressed and Schizophrenic Patients
Linnoila, M. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790040059008 · Cited by 150
M�ller, N., Ulmschneider, M., Scheppach, C., Schwarz, M., Ackenheil, M., M�ller, H.-J., Gruber, R., & Riedel, M. J. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0478-1 · Cited by 143
Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep quality
Prather, A. A., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.07.001 · Cited by 139
Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia
Rapaport, M. H., Delrahim, K. K., Bresee, C. J., Maddux, R. E., Ahmadpour, O. A., & Dolnak, D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.024 · Cited by 137
Inflammatory Biomarkers and Depression
Müller, N., Myint, A.-M., & Schwarz, M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9210-2 · Cited by 126
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
Müller, N. (2010) · PubMed · Cited by 122
McNamara, R. K., Jandacek, R. J., Rider, T., Tso, P., Cole-Strauss, A., & Lipton, J. W. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.08.004 · Cited by 118
Myint, A.-M., Steinbusch, H. W. M., Goeghegan, L., Luchtman, D. W., Kim, Y. K., & Leonard, B. E. (2007) · NeuroImmunoModulation · doi:10.1159/000107420 · Cited by 109
Müller, N., Myint, A.-M., & Schwarz, M. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/nmueller · Cited by 92
Changes in the immune system in depression and dementia: causal or co‐incidental effects?
Leonard, B. E. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(01)00014-4 · Cited by 91
Su, S., Miller, A. H., Snieder, H., Bremner, J. D., Ritchie, J., Maisano, C., Jones, L. R., Murrah, N. V., Goldberg, J. H., & Vaccarino, V. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31819082ef · Cited by 89
Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function
Hu, F., Wang, X., Pace, T. W. W., Wu, H., & Miller, A. H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001644 · Cited by 70
Chen, L., Li, D. Q., Zhong, J., Wu, X., Chen, Q., Peng, H., & Liu, S. Q. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.01.018 · Cited by 69
Liu, Y., Liu, A., Li, H., Li, C., & Lin, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0317 · Cited by 65
Abolfazli, R., Hosseini, M., Ghanizadeh, A. J., Ghaleiha, A., Tabrizi, M. H., Raznahan, M., Golalizadeh, M., & Akhondzadeh, S. (2011) · Depression and Anxiety · doi:10.1002/da.20801 · Cited by 60
Self-citationTipton, D. A., Flynn, J. C., Stein, S. H., & Dabbous, M. K. (2003) · Journal of Periodontology · doi:10.1902/jop.2003.74.12.1754 · Cited by 57
COX-2 inhibitors as adjunctive therapy in schizophrenia
Müller, N., Strassnig, M., Schwarz, M., Ulmschneider, M., & Riedel, M. J. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.8.1033 · Cited by 41
Humphreys, D., Liana Schlesinger, F., López, M., & Araya, A. V. (2006) · Endocrine · doi:10.1007/s12020-006-0016-1 · Cited by 30
When Should You Move Beyond First-Line Therapy for Depression?
McIntyre, R. S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.9104su1c.03 · Cited by 27
El‐Ghazaly, M. A., Nada, A. S., El‐Hazek, R. M., & Khayyal, M. T. (2010) · International Journal of Radiation Biology · doi:10.3109/09553002.2010.501839 · Cited by 26
Maintenance therapy of celecoxib for major depression with mimicking neuropsychological dysfunction
Chen, C., Tzeng, N., & Chen, Y.-C. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.07.001 · Cited by 25
The effects of celecoxib augmentation on cytokine levels in schizophrenia
Bresee, C. J., Delrahim, K. K., Maddux, R. E., Dolnak, D., Ahmadpour, O. A., & Rapaport, M. H. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005808 · Cited by 20
Augmentation and Combination Strategies for Complicated Depression
Fava, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.8001tx13c · Cited by 18
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Müller, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby024 · Cited by 648
Inflamed moods: A review of the interactions between inflammation and mood disorders
Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.013 · Cited by 609
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.007 · Cited by 596
Self-citation
Metadata
- Authors
- Abbasi, S.-H., Hosseini, F., Modabbernia, A., Ashrafi, M., & Akhondzadeh, S.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 141
- Issue
- 2-3
- Pages
- 308-314
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2102204071
- Cited by
- 339
- References
- 49
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.